Drug Guide
Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride
Classification
Therapeutic: Combination decongestant and antihistamine
Pharmacological: Sympathomimetic agent and H1 antihistamine
FDA Approved Indications
- Relief of nasal congestion and allergic rhinitis symptoms
Mechanism of Action
Pseudoephedrine acts as a sympathomimetic, causing vasoconstriction in nasal mucosa to relieve congestion. Triprolidine is an H1 antihistamine that blocks histamine receptors, reducing allergy symptoms.
Dosage and Administration
Adult: Typically 60 mg pseudoephedrine and 2.5 mg triprolidine every 4-6 hours as needed. Do not exceed 4 doses in 24 hours.
Pediatric: Use only if prescribed; dosages vary based on age and weight.
Geriatric: Start with lower doses due to potential for increased sensitivity.
Renal Impairment: Adjustments may be necessary; consult clinical guidelines.
Hepatic Impairment: Use with caution; no specific dose adjustment established.
Pharmacokinetics
Absorption: Well absorbed from gastrointestinal tract.
Distribution: Widely distributed; crosses blood-brain barrier.
Metabolism: Pseudoephedrine minimally metabolized, mainly excreted unchanged. Triprolidine metabolized hepatically.
Excretion: Primarily renal.
Half Life: Pseudoephedrine: ~6 hours; Triprolidine: ~7 hours.
Contraindications
- Severe hypertension
- Use within 14 days of MAOI therapy
- History of hypersensitivity to components
Precautions
- Hypertension, cardiovascular disease, BPH, glaucoma, hyperthyroidism, use caution in elderly and those with renal or hepatic impairment.
Adverse Reactions - Common
- Insomnia (Common)
- Dizziness (Common)
- Dry mouth (Common)
- Drowsiness (less with triprolidine) (Common)
Adverse Reactions - Serious
- Serious hypertensive reactions, especially with excessive dosing or in hypertensive patients (Rare)
- Central nervous system stimulation or depression (Rare)
- Allergic reactions, including rash, urticaria (Rare)
Drug-Drug Interactions
- Monoamine oxidase inhibitors (MAOIs) — may cause hypertensive crisis
- CNS depressants — enhanced sedation
Drug-Food Interactions
- Avoid excessive caffeine — may increase side effects
Drug-Herb Interactions
N/ANursing Implications
Assessment: Monitor blood pressure, cardiovascular status, and response to therapy.
Diagnoses:
- Risk for hypertension
- Impaired sleep pattern
- Potential for CNS depression or stimulation
Implementation: Administer with food to reduce gastrointestinal upset; monitor patient response.
Evaluation: Assess relief of nasal congestion and allergy symptoms, monitor for adverse effects.
Patient/Family Teaching
- Take as directed, do not exceed recommended dose.
- Avoid alcohol and CNS depressants.
- Caution about possible sedation and impairment.
- Inform about potential for increased blood pressure.
Special Considerations
Black Box Warnings:
- Potential for CNS stimulation leading to insomnia, nervousness, or anxiety.
- Contraindicated in patients with severe hypertension or on monoamine oxidase inhibitors.
Genetic Factors: N/A
Lab Test Interference: N/A
Overdose Management
Signs/Symptoms: Severe hypertension, agitation, hallucinations, seizures, coma, respiratory depression.
Treatment: Supportive care; monitor vital signs; administer medications to control blood pressure; activated charcoal if ingestion was recent; seek emergency care.
Storage and Handling
Storage: Store at room temperature, away from light and moisture.
Stability: Stable under recommended storage conditions.